In vitro effects of immunosuppressive agents on cytokine production by HTLV-I-infected T cell clones derived from the ocular fluid of patients with HTLV-I uveitis

Microbiology and Immunology

Volumn 40, Issue 5, 1996, Pages 373-379

  Sagawa, Kimitaka ^a   Mochizuki, Manabu ^a   Katagiri, Kazuko ^a   Tsuboi, Izumi ^a   Sugita, Sunao ^a   Mukaida, Naofumi ^b   Itoh, Kyogo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cytokines; HTLV I uveitis; Immunosuppressants; T cell clones

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 8; PHYTOHEMAGGLUTININ; PROSTAGLANDIN E2; RAPAMYCIN; RECOMBINANT INTERLEUKIN 2; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE CLONE; MONONUCLEAR CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; UVEITIS;

EID: 0030013585     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1996.tb01082.x     Document Type: Article

References (40)

1. 2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J. Immunol. 148: 2845-2852.
2. 2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression. J. Immunol. 135: 1172-1179.
3. Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., and Baumann, H. 1987. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. U.S.A. 84: 7251-7255.
4. Gessain, A., Barin, F., Vernant, J.C., Gout, O., Maurs, L., Calender, A., and de The, G. 1985. Antibodies to the human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii: 407-410.
5. Herbort, C.P., Okumura, A., and Mochizuki, M. 1989. Immunopharmacological analysis of endotoxin-induced uveitis in the rat. Exp. Eye Res. 48: 693-705.
6. Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K., Shirakawa, S., and Miyoshi, I. 1981. Adult T cell leukemia: antigen in an ATL cell line and detection of antibodies to antigen in human sera. Proc. Natl. Acad. Sci. U.S.A. 78: 6476-6480.
7. Katsikis, P.D., Chu, C., Brennan, F.M., Maini, R.N., and Feldmann, M. 1994. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 179: 1517-1527.
8. Kawashima, H., Fujino, Y., and Mochizuki, M. 1988. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats. Invest. Ophthalmol. Vis. Sci. 29: 1265-1271.
9. Kino, T., Hatanaka, H., Hashimoto, M., Nishiyama, M., Gott, T., Okuhara, M., Kohsaka, M., Aoki, H., and Imanaka, H. 1987. FK506, a novel immunosuppressant isolated from a Streptomycetes. I. Fermentation, isolation, and physicochemical and biological characteristics. J. Antibiot. 60: 1249-1255.
10. Ko, Y.-C., Mukaida, N., Ishiyama, S., Tokue, A., Kawai, T., Matsushima, K., and Kasahara, T. 1993. Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect. Immun. 61: 1307-1314.
11. Krause, D.S., and Deutsch, C. 1991. Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. J. Immunol. 146: 2285-2294.
12. Matsubara, T., Furukawa, S., and Yabuta, K. 1990. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesions. Clin. Immunol. Immunopathol. 56: 29-36.
13. 2. J. Immunol. 145: 2616-2625.
14. Mochizuki, M., and De Smet, M. 1994. Use of Immunosuppressive agents in ocular disease. Prog. Ret. Eye Res. 13: 479-506.
15. Mochizuki, M., Nussenblatt, R.B., Kuwabara, T., and Gery, I. 1985. Effects of cyclosporine and other immunosuppressive drugs on experimental autoimmune uveoretinitis in rats. Invest. Ophthalmol. Vis. Sci. 26: 226-232.
16. Mochizuki, M., Tajima, K., Watanabe, T., and Yamaguchi, K. 1994. Human T lymphotropic virus type I uveitis. Br. J. Ophthalmol. 78: 149-154.
17. Mochizuki, M., Watanabe, T., Yamaguchi, K., Takatsuki, K., Yoshimura, K., Shirao, M., Nakashima, S., Mori, S., Araki, S., and Miyata, N. 1992. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn. J. Cancer Res. 83: 236-239.
18. Mochizuki, M., Watanabe, T., Yamaguchi, K., Yoshimura, K., Nakashima, S., Shirao, M., Araki, S., Takatsuki, K., Mori, S., and Miyata, N. 1992. Uveitis associated with human T-cell lymphotropic virus type I. Am. J. Ophthalmol. 114: 123-129.
19. Mochizuki, M., Yamaguchi, K., Takatsuki, K., Watanabe, T., Mori, S., and Tajima, K. 1992. HTLV-I and uveitis. Lancet 339: 1110.
20. Mosmann, T.R., and Coffmann, R.L. 1987. Two types of mouse helper T-cell clones. Immunol. Today 8: 223-227.
21. Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., and Tara, M. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet i: 1031-1032.
22. + T cell clones. J. Immunol. 141: 849-855.
23. Pober, J.S., Bevilacqua, M.P., Mendrick, D.L., Lapierre, L.A., Fiers, W., and Gimbrone, J.M.A. 1986. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induces biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J. Immunol. 136: 1680-1687.
24. Pober, J.S., Gimbrone, J.M.A., Laperre, L.A., Mendrick, D.L., Fiers, W., Rothlein, R., and Springer, T.A. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137: 1893-1896.
25. Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna, J.D., and Gallo, R.C. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc. Natl. Acad. Sci. U.S.A. 77: 7415-7419.
26. Rameshwar, P., Ganea, D., and Gascon, P. 1994. Introduction of IL-3 granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6. J. Immunol. 152: 4044-4054.
27. 2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells. Eur. J. Immunol. 18: 1791-1796.
28. Sagawa, K., Itoh, K., Sakaguchi, M., Tamai, M., Sugita, S., Mukaida, N., Matsushima, K., and Mochizuki, M. 1995. Production of IL-8 and the other cytokines by T cell clones established from the ocular fluid of patients with Behçet's disease. Ocular Immunol. Inflamm. 3: 63-71.
29. Sagawa, K., Mochizuki, M., Masuoka, K., Katagiri, K., Katayama, T., Maeda, T., Tanimoto, A., Sugita, S., Watanabe, T., and Itoh, K. 1995. Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J. Clin. Invest. 95: 852-858.
30. Shimizu, K., Hirano, T., Ishibashi, K., Nakano, N., Taga, T., Sugamura, K., Yamamura, Y., and Kishimoto, T. 1985. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II). J. Immunol. 134: 1728-1733.
31. Sodroski, J. 1992. The human T-cell leukemia virus (HTLV) transactivator (Tax) protein. Biochim. Biophys. Acta 1114: 19-29.
32. Sugamura, K., Matsuyama, M., Fujii, M., Kannagi, M., and Hinuma, Y. 1983. Establishment of human cell lines constitutively producing immune interferon: transformation of normal T cells by a human retrovirus. J. Immunol. 131: 1611-1612.
33. Sugita, S., Sagawa, K., Mochizuki, M., Shichijo, S., and Itoh, K. 1996. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int. Immunol. 8 (in press).
34. Sulahuddin, S.Z., Markham, P.D., Lindner, S.G., Gootenberg, J., Popovic, M., Hemmi, H., Sarin, PS., and Gallo, R.C. 1984. Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I. Science 223: 703-707.
35. Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., and Uchino, H. 1977. Adult T cell leukemia: clinical and hematological features of 16 cases. Blood 50: 481-492.
36. 2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process. Cell. Immunol. 104: 24-36.
37. Vezina, C., Kudelski, A., and Sehgal, S.N. 1975. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. 28: 721-726.
38. Wano, Y., Hattori, T., Matsuoka, M., Takatsuki, K., Chua, A.O., Gubler, U., and Green, W.C. 1987. Interleukin 1 gene expression in adult T cell leukemia. J. Clin. Invest. 80: 911-916.
39. 2 on ThO-type human T cell clones: modulation of functions of nuclear proteins involved in cytokine production. Int. Immunol. 6: 523-532.
40. Yoshimura, K., Mochizuki, M., Araki, S., Miyata, N., Yamaguchi, K., Tajima, K., and Watanabe, T. 1993. Clinical and immunological features of human T-cell lymphotropic virus type I uveitis. Am. J. Ophthalmol. 116: 156-163.